Business Information
The group's principal activities are to develop, acquire, manufacture and market technologically distinguished branded and generic prescription pharmaceutical products. The group also develops, manufactures and markets raw material products for pharmaceutical, nutritional, personal care, food and other markets. The operations of the group are carried out through its three wholly owned subsidiaries: the branded pharmaceutical operations are conducted through ther-rx corporation. The generic pharmaceutical operations are conducted through ethex corporation with emphasis on the cardiovascular, women's health, pain management and respiratory areas. Particle dynamics, inc. Focus on development, manufacture and marketing of technologically advanced, value-added raw material products.
|
|
Name |
Title
|
Email
|
| Catherine Biffignani | VP - Investor Relations | N/A | | Richard Chibnall | VP - Finance | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 367,618 | 15,787 | | 2005 | 303,493 | 33,269 | | 2004 | 283,941 | 45,848
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
